Adrixetinib is a tyrosine kinase inhibitor with potential use as an antineoplastic agent.
For research use only. We do not sell to patients.
| Name | Adrixetinib ( Q-702 ) |
|---|---|
| Iupac Chemical Name | N-{5-[(6,7-dimethoxyquinolin-4-yl)oxy]pyridin-2-yl}-1- propyl-4-(2,2,2-trifluoroethoxy)-1H-pyrazole-3- carboxamide |
| Synonyms | Q-702 ; Adrixetinib ; |
| Molecular Formula | C25H24F3N5O5 |
| Molecular Weight | 531.48 |
| Smile | O=C(C1=NN(CCC)C=C1OCC(F)(F)F)NC2=NC=C(OC3=CC=NC4=CC(OC)=C(OC)C=C34)C=C2 |
| InChiKey | BWUUJXXFCSYLFW-UHFFFAOYSA-N |
| InChi | InChI=1S/C25H24F3N5O5/c1-4-9-33-13-21(37-14-25(26,27)28)23(32-33)24(34)31-22-6-5-15(12-30-22)38-18-7-8-29-17-11-20(36-3)19(35-2)10-16(17)18/h5-8,10-13H,4,9,14H2,1-3H3,(H,30,31,34) |
| CAS Number | 2394874-66-7 |
| Related CAS | 2991273-39-1 (HCl salt) |
| Packaging | Price | Availability | Purity | Shipping Time |
|---|---|---|---|---|
| Bulk | Enquiry | Enquiry | Enquiry |
| Formulation | Solid powder |
|---|---|
| Purity | 98% Min. |
| Storage | Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years). |
| Solubility | Soluble in DMSO |
| Handling | |
| Shipping Condition | Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs. |
| HS Code |
| Targets | |
|---|---|
| Mechanism | |
| Cell study | |
| Animal study | |
| Clinical study |